SynCardia gains FDA OK for portable artificial heart driver | Group looks to invest up to $60M in life sciences startups | Illumina buys companion Dx consulting firm
Web Version
 
July 17, 2014
ADVAMED SmartBrief
News for medical technology professionals
SIGN UP|FORWARD|ARCHIVE|ADVERTISE

Top StorySponsored By
SynCardia gains FDA OK for portable artificial heart driver
The FDA has granted SynCardia Systems approval to market the Freedom driver for use with the company's Total Artificial Heart. The portable driver, which already has marketing approval in Canada and Europe, allows clinically stable patients implanted with the company's Total Artificial Heart to leave the hospital while awaiting a transplant. Arizona Daily Star (Tucson) (7/16)
Share: LinkedInTwitterFacebookGoogle+Email
Learn How Analytics Outsourcing Can Become a Competitive Advantage
You've heard it before: outsourcing your analytics can improve customer segmentation, pinpoint cross- and upselling opportunities, and find new ways to deliver value--and do so more efficiently and effectively. Yet few med device companies do this today. However, a reticence to outsource analytics may prove to be a strategic blunder in the coming years. View this video to learn how analytics outsourcing can be a competitive advantage for your company.
 
Business & Market Trends
Group looks to invest up to $60M in life sciences startups
A fund worth as much as $60 million is being raised by the New York City Economic Development Corp. in an effort to foster biotech innovation in the city. The group plans to invest the money in early-stage companies developing diagnostics, medical devices and other life sciences technologies. Xconomy/New York (7/16)
Share: LinkedInTwitterFacebookGoogle+Email
Illumina buys companion Dx consulting firm
Illumina has agreed to pay an undisclosed sum to purchase Myraqa, which provides regulatory and quality consulting services related to companion diagnostic tests. Illumina said the deal will strengthen its "in-house capabilities for clinical readiness and help prepare [the firm] for its next growth phase in regulated markets." GenomeWeb Daily News (free registration) (7/16), San Diego Business Journal (7/16)
Share: LinkedInTwitterFacebookGoogle+Email
Medbio breaks ground on $3.39M facility expansion in Mich.
Medbio has initiated a project to expand its production and warehouse facility in Cascade Township, Mich. The Michigan Strategic Fund is providing tax breaks and a performance-based grant worth $180,000 for the project, which is expected to cost $3.39 million. The expansion could generate 45 new positions in the area in the next three years. MLive.com (Michigan) (free registration) (7/16)
Share: LinkedInTwitterFacebookGoogle+Email
International Developments
Report: Global medical polymer market could hit $7.05B by 2020
The growing use of high performance polymers to replace metal and glass in medical devices could help the worldwide medical polymer market hit $7.05 billion in six years, according to a Grand View Research report. North America dominated the market last year, but Asia is likely to play a key role in increasing medical polymer demand through 2020. Plastics & Rubber Weekly (U.K.) (7/16)
Share: LinkedInTwitterFacebookGoogle+Email
Industry Insight
Podcast: Medical device execs discuss M&A activity
MassDevice
MassDevice.com speaks to 3M's Deb Rectenwald, St. Jude Medical's Philip Ebeling and Nadim Yared, CEO of CVRx, about the environment for medtech M&A and other trends affecting the industry. Listen to the podcast.
Share: LinkedInTwitterFacebookGoogle+Email
 
Science & Health
BioTheranostics gets OK to distribute breast cancer Dx in N.Y.
BioTheranostics has received the go-ahead to distribute its Breast Cancer Index in New York. The molecular diagnostic assay measures a patient's risk of recurrent estrogen receptor-positive breast cancer and determines whether extended endocrine treatment will benefit the patient. GenomeWeb Daily News (free registration) (7/16)
Share: LinkedInTwitterFacebookGoogle+Email
Emerging Technologies
Covidien's soft tissue ablation device could hit market in Q3
Covidien said its Emprint system, which was cleared by the FDA in April, could be available commercially in the third quarter. The device is intended to ablate diseased soft tissue in the lung, kidney and liver using the company's Thermosphere technology. MassDevice.com (Boston) (7/16)
Share: LinkedInTwitterFacebookGoogle+Email
Cartilage allograft kit from RTI debuts at conference
A device used for osteochondral allograft resurfacing was introduced by RTI Surgical at a recent sports medicine conference in Seattle. The Precision Allograft Cartilage Kit employs a surgical technique that supports enhanced accuracy and reduced cartilage trauma. BeckersSpine.com (7/16)
Share: LinkedInTwitterFacebookGoogle+Email
Government & Regulatory
DorsaVi's activity-monitoring device lands FDA clearance
The FDA has cleared dorsaVi to market its ViMove system for use in clinical settings or athletic training. The technology uses sensors to monitor muscle activity and movement, and wirelessly sends those readings to a computer for evaluation by physicians. MobiHealthNews.com (7/16)
Share: LinkedInTwitterFacebookGoogle+Email
FDA clears IBA's compact gantry for proton therapy device
Ion Beam Applications has been cleared by the FDA to market its Compact Gantry Beam Line, which will be integrated with the company's ProteusOne device used for single-room proton therapy. AuntMinnie.com (free registration) (7/16)
Share: LinkedInTwitterFacebookGoogle+Email
AdvaMed News
Helping medical technology professionals keep pace with regulatory and compliance issues
AdvaMed-MTLI and UL EduNeering have recently launched the AdvaMed Regulatory and Compliance Certificate (ARCC) Program for Medical Technology Professionals. The ARCC Program is a relevant and timely collaboration between AdvaMed and UL EduNeering that helps medical technology professionals to expand their knowledge of quality, regulatory and compliance topics. Learn more.
Share: LinkedInTwitterFacebookGoogle+Email
Follow AdvaMed on Google+
Stay updated on industry news and educational opportunities -- receive an intimate understanding of the key issues affecting innovation, access and the bottom line. Network with industry experts and leaders. Our Google+ page is interactive and incorporates updates from key stakeholders, influencers and industry thought leaders as well as regulatory and policy experts from the FDA and CMS. Follow us on Google+.
Share: LinkedInTwitterFacebookGoogle+Email
 
Who's Hiring?
Position TitleCompany NameLocation
Regulatory Affairs SpecialistBecton DickinsonFranklin Lakes, NJ
MGR CLINICAL RESEARCH - 14000003MBAbbottSanta Clara, CA
Director of Clinical Research Regenesis Biomedical, Inc.Scottsdale, AZ
Click here to view more job listings.
 
SmartQuote
Be brave enough to start a conversation that matters."
-- Margaret Wheatley,
American writer
Share: LinkedInTwitterFacebookGoogle+Email
Learn more about AdvaMed ->About AdvaMed | Join | Courses | Events | Newsroom
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
 
Editor:  Lisa Gough
Advertising:  Meryl Harold
  P: 202.407.7828
Jobs Contact:  Jackie Basso
  P: 202.407.7871
 
 

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2014 SmartBrief, Inc.®
Privacy policy |  Legal Information